Characterizing the ovotoxicity of cyclophosphamide metabolites on cultured mouse ovaries

Toxicological Sciences

Volumn 90, Issue 2, 2006, Pages 500-509

  Desmeules, Patrice ^a   Devine, Patrick J ^a  

^a INSTITUT NATIONAL DE LA RECHERCHE SCIENTIFIQUE   (Canada)

Author keywords

Chemotherapy; Cyclophosphamide; Follicle; In vitro; Mouse; Ovarian toxicity; Phosphoramide mustard

Indexed keywords

4 HYDROPEROXYCYCLOPHOSPHAMIDE; 4 OXOCYCLOPHOSPHAMIDE; ACROLEIN; CASPASE 3; CYCLOPHOSPHAMIDE; DRUG METABOLITE; PHOSPHORAMIDE MUSTARD;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EXPOSURE; DRUG SENSITIVITY; FEMALE; GRANULOSA CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALE; MORPHOLOGY; MOUSE; NICK END LABELING; NONHUMAN; OOCYTE; OVARY; OVARY FOLLICLE; PERINATAL PERIOD; REPRODUCTIVE TOXICITY; STATISTICAL ANALYSIS; TARGET CELL; TISSUE CULTURE;

ACROLEIN; ANIMALS; CYCLOPHOSPHAMIDE; FEMALE; MALE; MICE; MICE, INBRED STRAINS; OVARIAN FOLLICLE; PHOSPHORAMIDE MUSTARDS;

ANIMALIA; RODENTIA;

EID: 33645119762     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfj086     Document Type: Article

References (38)

1. Anderson, D., Bishop, J. B., Garner, R. C., Ostrosky-Wegman, P., and Selby, P. B. (1995). Cyclophosphamide: Review of its mutagenicity for an assessment of potential germ cell risks. Mutat. Res. 330, 115-181.
2. Baumann, F., Lorenz, C., Jaehde, U., and Preiss, R. (1999). Determination of cyclophosphamide and its metabolites in human plasma by high-performance liquid chromatography-mass spectrometry. J. Chromatogr B Biomed. Sci. Appl. 729, 297-305.
3. Cai, Y., Wu, M. H., Xu-Welliver, M., Pegg, A. E., Ludeman, S. M., and Dolan, M. E. (2000). Effect of O6-benzylguanine on alkylating agent-induced toxicity and mutagenicity. In Chinese hamster ovary cells expressing wild-type and mutant O6-alkylguanine-DNA alkyltransferases. Cancer Res. 60, 5464-5469.
4. Christiansen, C., Christensen, M. S., McNair, P., Hagen, C., Stocklund, K. E., and Transbol, I. (1980). Prevention of early postmenopausal bone loss: Controlled 2-year study in 315 normal females. Eur. J. Clin. Invest. 10, 273-279.
5. Colvin, M., Brundrett, R. B., Kan, M. N., Jardine, I., and Fenselau, C. (1976). Alkylating properties of phosphoramide mustard. Cancer Res. 36, 1121-1126.
6. Devine, P. J., Sipes, I. G., and Hoyer, P. B. (2004). Initiation of delayed ovotoxicity by in vitro and in vivo exposures of rat ovaries to 4-vinyl-cyclohexene diepoxide. Reprod. Toxicol. 19, 71-77.
7. Engle, T. W., Zon, G., and Egan, W. (1982). 31P NMR kinetic studies of the intra- and intermolecular alkylation chemistry of phosphoramide mustard and cognate N-phosphorylated derivatives of N,N-bis(2-chloroethyl)amine. J. Med. Chem. 25, 1347-1357.
8. Fenwick, M. A., and Hurst, P. R. (2002). Immunohistochemical localization of active caspase-3 in the mouse ovary: Growth and atresia of small follicles. Reproduction 124, 659-665.
9. First line physicians (2002). Canadian Fertility and Andrology Society consensus document for the investigation of infertility.
10. Flowers, J. L., Ludeman, S. M., Gamcsik, M. P., Colvin, O. M., Shao, K. L., Boal, J. H., Springer, J. B., and Adams, D. J. (2000). Evidence for a role of chloroethylaziridine in the cytotoxicity of cyclophosphamide. Cancer Chemother. Pharmacol. 45, 335-344.
11. Hales, B. F. (1982). Comparison of the mutagenicity and teratogenicity of cyclophosphamide and its active metabolites, 4-hydroxycyclophosphamide, phosphoramide mustard, and acrolein. Cancer Res. 42, 3016-3021.
12. Hales, B. F., Aguilar-Mahecha, A., and Robaire, B. (2005). The stress response in gametes and embryos after paternal chemical exposures. Toxicol. Appl. Pharmacol. 27, 514-520.
13. Hirshfield, A. N. (1991). Development of follicles in the mammalian ovary. Int. Rev. Cytol. 124, 43-101.
14. Hoyer, P. B., and Devine, P. J. (2002). Endocrinology and toxicology: The female reproductive system. In Handbook of Toxicology, (M. J. Derelank, Ed.), pp. 573-596, Boca Raton, Hollinger MA.
15. Hoyer, P. B., and Sipes, I. G. (1996). Assessment of follicle destruction in chemical-induced ovarian toxicity. Annu. Rev. Pharmacol. Toxicol. 36, 307-331.
16. Hu, X., Christian, P., Sipes, I. G., and Hoyer, P. B. (2001a). Expression and redistribution of cellular Bad, Bax, and Bcl-X(L) protein is associated with VCD-induced ovotoxicity in rats. Biol. Reprod. 65, 1489-1495.
17. Hu, X., Christian, P. J., Thompson, K. E., Sipes, I. G., and Hoyer, P. B. (2001b). Apoptosis induced in rats by 4-vinylcyclohexene diepoxide is associated with activation of the caspase cascades. Biol. Reprod. 65, 87-93.
18. Inoue, S., Watanabe, H., Saito, H., Hiroi, M., and Tonosaki, A. (2000). Elimination of atretic follicles from the mouse ovary: A TEM and immunohistochemical study in mice. J. Anat. 196, 103-110.
19. Jansen, R. P., and de Boer, K. (1998). The bottleneck: Mitochondrial imperatives in oogenesis and ovarian follicular fate. Mol. Cell. Endocrinol. 145, 81-88.
20. Jarrell, J. F., Bodo, L., YoungLai, E. V., Barr, R. D., and O'Connell, G. J. (1991). The short-term reproductive toxicity of cyclophosphamide in the female rat. Reprod. Toxicol. 5, 481-485.
21. Leist, M., and Jaattela, M. (2101). Four deaths and a funeral: From caspases to alternative mechanisms. Nat. Rev. Mol. Cell. Biol. 2, 589-598.
22. Ludeman, S. M. (1999). The chemistry of the metabolites of cyclophosphamide. Curr. Pharm. Des. 5, 627-643.
23. Ludeman, S. M., Ho, C. K., Boal, J. H., Sweet, E. M., and Chang, Y. H. (1992). Carboxyphosphamide: NMR studies of its stability and cell membrane permeability. Drug Metab. Dispos. 20, 337-338.
24. Matikainen, T., Perez, G. I., Zheng, T. S., Kluzak, T. R., Rueda, B. R., Flavell, R. A., and Tilly, J. L. (2001). Caspase-3 gene knockout defines cell lineage specificity for programmed cell death signaling in the ovary. Endocrinology 142, 2468-2480.
25. Meirow, D., Lewis, H., Nugent, D., and Epstein, M. (1999). Subclinical depletion of primordial follicular reserve in mice treated with cyclophosphamide: Clinical importance and proposed accurate investigative tool. Hum. Reprod. 14, 1903-1907.
26. Nikolaou, D., and Templeton, A. (2004). Early ovarian ageing. Eur. J. Obstet. Gynecol. Reprod. Biol. 113, 126-133.
27. Oparil, S. (1999). Treating multiple-risk hypertensive populations. Am. J. Hypertens. 12, 121S-129S.
28. Paganini-Hill, A., and Henderson, V. W. (1994). Estrogen deficiency and risk of Alzheimer's disease in women. Am. J. Epidemiol. 140, 256-261.
29. Perez, G. I., Knudson, C. M., Leykin, L., Korsmeyer, S. J., and Tilly, J. L. (1997). Apoptosis-associated signaling pathways are required for chemotherapy-mediated female germ cell destruction. Nat. Med. 3, 1228-1232.
30. Perez, G. I., Tao, X. J., and Tilly, J. L. (1999). Fragmentation and death (a.k.a. apoptosis) of ovulated oocytes. Mol. Hum. Reprod. 5, 414-420.
31. Plowchalk D. R., and Mattison, D. R. (1991). Phosphoramide mustard is responsible for the ovarian toxicity of cyclophosphamide. Toxicol. Appl. Pharmacol. 107, 472-481.
32. Plowchalk, D. R., and Mattison, D. R. (1992). Reproductive toxicity of cyclophosphamide in the C57BL/6N mouse: 1. Effects on ovarian structure and function. Reprod. Toxicol. 6, 411-421.
33. Shulman-Roskes, E. M., Noe, D. A., Gamcsik, M. P., Marlow, A. L., Hilton, J., Hausheer, F. H., Colvin, O. M., and Ludeman, S. M. (1998). The partitioning of phosphoramide mustard and its aziridinium ions among alkylation and P-N bond hydrolysis reactions. J. Med. Chem. 41, 515-529.
34. Struck, R. F., Alberts, D. S., Horne, K., Phillips, J. G., Peng, Y. M., and Roe, D. J. (1987). Plasma pharmacokinetics of cyclophosphamide and its cytotoxic metabolites after intravenous versus oral administration in a randomized, crossover trial. Cancer Res. 47, 2723-2726.
35. Takai, Y., Canning, J., Perez, G. I., Pru, J. K., Schlezinger, J. J., Sherr, D. H., Kolesnick, R. N., Yuan, J., Flavell, R. A., Korsmeyer, S. J., et al. (2003). Bax, caspase-2, and caspase-3 are required for ovarian follicle loss caused by 4-vinylcyclohexene diepoxide exposure of female mice in vivo. Endocrinology 144, 69-74.
36. Telfer, E. E., Gosden, R. G., Byskov, A. G., Spears, N., Albertini, D., Andersen, C. Y., Anderson, R., Braw-Tal, R., Clarke, H., Gougeon, A., et al. (2005). On regenerating the ovary and generating controversy. Cell 122, 821-822.
37. Tilly, J. L., Kowalski, K. I., Johnson, A. L., and Hsueh, A. J. (1991). Involvement of apoptosis in ovarian follicular atresia and postovulatory regression. Endocrinology 129, 2799-2801.
38. Zon, G., Ludeman, S. M., Brandt, J. A., Boyd, V. L., Ozkan, G., Egan, W., and Shao, K. L. (1984). NMR spectroscopic studies of intermediary metabolites of cyclophosphamide. A comprehensive kinetic analysis of the interconversion of cis- and trans-4-hydroxycyclophosphamide with aldophosphamide and the concomitant partitioning of aldophosphamide between irreversible fragmentation and reversible conjugation pathways. J. Med. Chem. 27, 466-485.